Heparanase expression correlates with metastatic capability in human choriocarcinoma

Gynecologic Oncology

Volumn 107, Issue 1, 2007, Pages 22-29

  Jingting, Cai ^a   Yangde, Zhang ^b   Yi, Zhang ^a   Huining, Liu ^a   Rong, Yu ^a   Yu, Zhang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Antisense oligodeoxynucleotide; Choriocarcinoma; Heparanase; Invasive capability

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; HEPARANASE; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; CHORIOCARCINOMA; CHORION; FEMALE; GLUCURONIDASE; HUMANS; NEOPLASM METASTASIS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE NEOPLASMS;

EID: 34648814234     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.05.042     Document Type: Article

References (35)

1. Lala P.K., and Graham C.H. Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer Metastasis Rev. 9 4 (1990) 369-379
2. Liotta L.A., Rao C.N., and Wewer U.M. Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem. 55 (1986) 1037-1057
3. Staun-Ram E., Goldman S., Gabarin D., and Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod. Biol. Endocrinol. 4 2 (2004) 59
4. Isaka K., Usuda S., Ito H., Sagawa Y., Nakamura H., Nishi H., et al. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta 24 1 (2003) 53-64
5. Okamoto T., Niu R., Yamada S., and Osawa M. Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases. Mol. Hum. Reprod. 8 4 (2002) 392-398
6. Vegh G.L., Selcuk Tuncer Z., Fulop V., Genest D.R., Mok S.C., and Berkowitz R.S. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol. Oncol. 75 2 (1999) 248-253
7. Morgan M., Kniss D., and McDonnell S. Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines. Exp. Cell Res. 10 242(1) (1998) 18-26
8. Karmakar S., Dhar R., and Das C. Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway. J. Biol. Chem. 31 279(53) (2004) 55297-55307
9. Liu J., Chakraborty C., Graham C.H., Barbin Y.P., Dixon S.J., and Lala P.K. Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase. Exp. Cell Res. 15 286(1) (2003) 138-151
10. Jensen P.H., Christensen E.I., Ebbesen P., Gliemann J., and Andreasen P.A. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. Cell Regul. 1 13 (1990) 1043-1056
11. Kelly T., Suva L.J., Huang Y., Macleod V., Miao H.Q., Walker R.C., et al. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res. 1 65(13) (2005) 5778-5784
12. Joyce J.A., Freeman C., Meyer-Morse N., Parish C.R., and Hanahan D. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 9 24(25) (2005) 4037-4051
13. Roy M., Reiland J., Murry B.P., Chouljenko V., Kousoulas K.G., and Marchetti D. Antisense-mediated suppression of heparanase gene inhibits melanoma cell invasion. Neoplasia 3 (2005) 253-262
14. Liu Y.B., Gao S.L., Chen X.P., Peng S.Y., Fang H.Q., Wu Y.L., et al. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma. World J. Gastroenterol. 7 11(9) (2005) 1378-1381
15. Ogishima T., Shiina H., Breault J.E., Tabatabai L., Bassett W.W., Enokida H., et al. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin. Cancer Res. 1 11(3) (2005) 1028-1036
16. Murry B.P., Greiter-Wilke A., Paulsen D.P., Hiatt K.M., Beltrami C.A., and Marchetti D. Selective heparanase localization in malignant melanoma. Int. J. Oncol. 26 2 (2005) 345-352
17. Sato T., Yamaguchi A., Goi T., Hirono Y., Takeuchi K., Katayama K., et al. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. J. Surg. Oncol. 15 87(4) (2004) 174-181
18. Elkin M., Cohen I., Zcharia E., Guatta-Rangini Z., Peretz T., Vlodavsky I., et al. Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res. 15 63(24) (2003) 8821-8826
19. Kelly T., Miao H.Q., Yang Y., Navarro E., Kussie P., Huang Y., et al. High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res. 63 15 (2003) 8749-8756
20. Grummer R., Hohn H.P., Mareel M.M., and Denker H.W. Adhesion and invasion of three human choriocarcinoma cell lines into human endometrium in a three-dimensional organ culture system. Placenta 15 4 (1994) 411-429
21. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 5 (1999) 793-802
22. Staff A.C., Ranheim T., Henriksen T., and Halvorsen B. 8-Iso-prostaglandin F2 a reduces trophoblast invasion and matrix metalloproteinase activity. Hypertension 35 (2000) 1307-1313
23. Imamura H., Takao S., and Aikou T. A modified invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay for quantitating tumor cell invasion. Cancer Res. 54 (1994) 3620-3624
24. Kikkawa F. Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells. Nippon Sanka Fujinka Gakkai Zasshi 48 8 (1996) 618-622
25. Dey S.K., Lim H., Das S.K., Reese J., Paria B.C., Daikoku T., et al. Molecular cues to implantation. Endocr. Rev. 25 3 (2004) 341-373
26. Martin O., and Arias F. Plasminogen activator production by trophoblast cells in vitro: effect of steroid hormones and protein synthesis inhibitors. Am. J. Obstet. Gynecol. 15 142(4) (1982) 402-409
27. Liotta L.A. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am. J. Pathol. 117 3 (1984) 339-348
28. Kauma S.W. Cytokines in implantation. J. Reprod. Fertil. Suppl. 55 (2000) 31-42
29. Dempsey L.A., Brumn G.J., and Platt J.L. Human heparanase, a potent regulator of cell matrix interactions. Trends Biochem. Sci. 25 8 (2000) 349-351
30. Parish C.R., Freeman C., and Hulett M.D. Heparanase: a key enzyme involved in cell invasion. Biochim. Biophys. Acta 1471 3 (2001) M99-M108
31. Dong J., Kukula A.K., Toyoshima M., and Nakajima M. Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene 253 (2000) 171-178
32. Vlodavsky I., Fuks Z., Ishai-Michaeli R., Bashkin P., Levi E., Korner G., et al. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J. Cell. Biochem. 45 2 (1991) 167-176
33. Goshen R., Hochberg A.A., Korner G., Levy E., Ishai-Michaeli R., Elkin M., et al. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol. Hum. Reprod. 2 9 (1996) 679-684
34. Joyce J.A., Freeman C., Meyer-Morse N., Parish C.R., and Hanahan D. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 24 25 (2005) 4037-4051
35. Marchetti D., Reiland J., Erwin B., and Roy M. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues. Int. J. Cancer 104 2 (2003) 167-174